Ranolazine: Started Phase III

CV Therapeutics Inc. (CVTX), Palo Alto, Calif.
Product: Ranolazine
Business: Cardiovascular
Therapeutic category: Metabolism
Target: NA

Read the full 167 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE